Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma

The British Journal of Surgery
R T PoonS T Fan

Abstract

Vascular endothelial growth factor (VEGF) and endostatin stimulate and inhibit tumour angiogenesis respectively. Recent studies have demonstrated the prognostic value of serum levels of both VEGF and endostatin in patients with various types of cancer. Their significance in patients with hepatocellular carcinoma (HCC) remains unclear. Serum VEGF and endostatin levels were measured by enzyme immunoassay in 108 patients with HCC before surgical resection and in 20 healthy controls. Preoperative serum VEGF and endostatin levels were correlated with clinicopathological features and long-term survival. Serum VEGF levels in patients with HCC were significantly higher than those in controls, but serum levels of endostatin were similar in the two groups. High serum levels of VEGF, but not endostatin, were significantly associated with venous invasion and advanced tumour stage. Patients with a serum VEGF level higher than median (over 245.0 pg/ml) had significantly worse overall and disease-free survival than those with a lower level (P = 0.012 and P = 0.022 respectively). On multivariate analysis, serum VEGF level was an independent prognostic factor (hazard ratio 1.86 (95 per cent confidence interval 1.10 to 3.92); P = 0.032). Serum e...Continue Reading

References

Sep 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B LinderholmR Henriksson
Jul 1, 1999·Gynecologic Oncology·L HeflerA Obermair
Aug 25, 1999·British Journal of Haematology·F BertoliniG Martinelli
May 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D SmithB G Haffty
Aug 15, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M YamagataM Omata
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R T PoonJ Wong
Dec 26, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Makoto SuzukiTakehiko Fujisawa
Mar 5, 2002·British Journal of Cancer·K WertherUNKNOWN Danish RANX05 Colorectal Cancer Study Group
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronnie Tung-Ping PoonJohn Wong
Nov 2, 2002·Cancer·Dipok Kumar DharNaofumi Nagasue
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James P ThomasGeorge Wilding
May 9, 2003·Surgical Oncology Clinics of North America·Ronnie Tung-Ping Poon, Sheung-Tat Fan

❮ Previous
Next ❯

Citations

May 31, 2012·International Orthopaedics·Ramakant KumarLaxman Rijal
Sep 28, 2012·International Orthopaedics·Shishir RastogiMehar C Sharma
Nov 12, 2005·Bulletin of Experimental Biology and Medicine·T A BritvinN E Kushlinskii
Apr 17, 2008·Cancer Metastasis Reviews·Aaron P BrownKevin A Camphausen
Jan 30, 2013·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Jian-Hai GuoRen-Jie Yang
Aug 19, 2005·Current Treatment Options in Oncology·Jonathan Whisenant, Emily Bergsland
Mar 10, 2011·Nature Reviews. Clinical Oncology·Andrew X ZhuRakesh K Jain
Jun 19, 2007·Antioxidants & Redox Signaling·Eui Jung MoonMark W Dewhirst
May 31, 2012·American Journal of Clinical Oncology·Rangaswamy GovindarajanStephen Williamson
Aug 28, 2010·Journal of Gastroenterology and Hepatology·Lifang FanHanlin L Wang
Dec 24, 2010·Journal of Gastroenterology and Hepatology·Shenghua JieLi Jiang
Oct 21, 2011·Journal of Gastroenterology and Hepatology·Koji MiyaharaKazuhide Yamamoto
Mar 1, 2012·Journal of Gastroenterology and Hepatology·Stephen L Chan, Winnie Yeo
Jan 18, 2011·International Journal of Clinical Practice·R LordP J Ross
Aug 15, 2008·Cancer Research·Derek Y ChiangJosep M Llovet
Sep 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ahmed O KasebJames L Abbruzzese
Feb 1, 2008·Annals of Surgical Oncology·Sunil KrishnanFrancoise Mornex
Feb 1, 2008·Annals of Surgical Oncology·Roberta W C PangRonnie T P Poon
Apr 21, 2010·Annals of Surgical Oncology·Andrew X Zhu
Feb 27, 2007·Vascular Health and Risk Management·Roberta W C Pang, Ronnie T P Poon
Mar 19, 2009·World Journal of Gastroenterology : WJG·Asmaa I GomaaSimon D Taylor-Robinson
Oct 14, 2011·International Journal of Hepatology·Clarinda W L Chua, Su Pin Choo
Jun 14, 2013·Clinical Medicine Insights. Oncology·Zhengyu WeiYuan Liu
Apr 4, 2014·World Journal of Gastroenterology : WJG·Bang-Bin Chen, Tiffany Ting-Fang Shih
Apr 4, 2014·World Journal of Gastroenterology : WJG·Domenico Germano, Bruno Daniele
Oct 11, 2013·Future Oncology·Gaetano BertinoMichele Malaguarnera
Mar 31, 2012·Rheumatology International·James V DunneStephan F Van Eeden
Aug 5, 2014·BioMed Research International·Gaetano BertinoIsidoro Di Carlo
Jun 1, 2012·Clinical Journal of Gastroenterology·Goshi Shiota, Norimasa Miura
Feb 5, 2010·Expert Opinion on Emerging Drugs·Hung Huynh
Apr 7, 2010·Expert Opinion on Investigational Drugs·Andrew X Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved